Novavax (NVAX) Tops Q2 EPS by 8c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.22 -1.16%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.32), $0.08 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $57 million versus the consensus estimate of $52.06 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
